Effects of Moderate Physical Activity on Early Symptoms of Peripheral Diabetic Neuropathy in Type-II Diabetes: A Randomized Clinical Trial
1 other identifier
interventional
17
1 country
1
Brief Summary
This study determines the effects of moderate physical activity on early symptoms of peripheral diabetic neuropathy in type-II diabetes. Most of the literature shows the impact of physical activity to manage/controlling diabetes. Some studies were conducted on animals to study the impact of physical activity on diabetic neuropathy and neurogenesis. There is no study on the impact of physical activity to manage early symptoms of peripheral diabetic neuropathy in patients with type-II diabetes in humans. This study finds the impact of moderate physical activity to manage early symptoms of peripheral diabetic neuropathy in patients with type-II diabetes in humans.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2021
CompletedFirst Submitted
Initial submission to the registry
July 31, 2022
CompletedFirst Posted
Study publicly available on registry
August 8, 2022
CompletedAugust 8, 2022
August 1, 2022
2 months
July 31, 2022
August 4, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effect of moderate physical activity on early symptoms of peripheral diabetic neuropathy in type-II diabetes
Research Hypothesis
2 Months
Study Arms (2)
Moderate Physical Activity Group
EXPERIMENTALThe Experimental Group gets moderate physical activity. Elliptical will be performed at least 5 days/per week. Moderate intensity, corresponding approximately to 40-60% of Vo2max (maximal aerobic capacity) 150 min/week of exercise undertaken at moderate intensity or greater. Warm-up and Dynamic stretching is given before and static stretching is given after moderate physical activity.
Non Specific Physical Activity Group
NO INTERVENTIONThe Control group continues their regular medication for diabetic neuropathy.
Interventions
Moderate physical activity can increase movement and heart rate are particularly important for people suffering with peripheral neuropathy. Physical activity can improve blood circulation, which strengthens nerve tissues by increasing the flow of oxygen.
Eligibility Criteria
You may qualify if:
- Patients with Type-II Diabetes
- Diagnosed cases of Peripheral Diabetic Neuropathy
- Peripheral Diabetic Neuropathy Stage 1 \& 2
- Numbness or reduced ability to feel pain or temperature changes.
- Tingling or burning sensation.
- Sharp pains or cramps.
- Increased sensitivity to touch
- Males and females
- Age: 35-65
- HbA1c above 6.5
- Mild activity level on IPAQ-7 (\< 150min/per week)
- Berg Balance Scale score (\< 45)
You may not qualify if:
- Cardiac Issues
- Any neurological issue
- Lower limb deformity
- Acute injury
- Hip and Knee OA
- Patients with walking difficulty
- Diabetic foot
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
RHS Rehabilitation Center
Islamabad, Federal, 46000, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 31, 2022
First Posted
August 8, 2022
Study Start
October 1, 2021
Primary Completion
November 30, 2021
Study Completion
December 25, 2021
Last Updated
August 8, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share